VYNE Therapeutics Inc.
VYNE | NASDAQ
$28.56
$0.00 (0.00%)
Nov 2, 2026, 10:42 AM ET · Market open
TTM Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash & Equivalents | 24.03K | 24.63M | 24.03M | 19.35M | 22.05M | 28.21M | 19.93M | 16.27M | 29.61M | 19.12M | 30.62M | 15.45M | 20.63M | 30.21M | 30.91M | 35.51M | 42.81M | 50.5M | 42.25M | 52.31M | 103.41M | 118.52M |
Short-Term Investments | 4.98K | 297K | 4.98M | 13.35M | 17.6M | 22.06M | 41.59M | 53.91M | 48.49M | 66.89M | 62.63M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.03M |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 1.41K | n/a | 60K | 150K | 241K | 1.34M | 2.26M | 2.54M | 2.72M | 1.27M | 1.52M | 1.76M | 2M | 2.24M | 2.48M | 2.74M | 2.97M | 3.36M | 3.51M | 3.68M | 3.83M | 4.12M |
Receivables | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 250K | 234K | 105K | 5M | 5.47M | 5.3M | 5.54M | 7.58M | 10.08M | 10.87M | 10.76M |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 54K | 67K | n/a | n/a | n/a | n/a | n/a | 7.29M | 8.07M | 8.28M | 8.09M |
Other Current Assets | n/a | 861K | 1M | 3.19M | 4.7M | 4.64M | 2.92M | 3.35M | 5.68M | 4.22M | 2.71M | 1.76M | 2.02M | 67K | 240K | 67K | 30K | 729K | 1.5M | 605K | 605K | 855K |
Total Current Assets | 30.01K | 25.79M | 30.01M | 35.89M | 44.34M | 54.91M | 64.44M | 73.54M | 83.78M | 90.22M | 95.96M | 17.51M | 22.96M | 33.02M | 38.28M | 44.05M | 51.92M | 60.65M | 63.19M | 76.13M | 128.43M | 143.12M |
Property-Plant & Equipment | 90 | 84K | 90K | 96K | 134K | 169K | 206K | 122K | 151K | 180K | 207K | n/a | n/a | n/a | n/a | 127K | 298K | 310K | 354K | 1.51M | 1.73M | 1.94M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 1.5K | 84K | 150K | 246K | 375K | 1.51M | 2.47M | 2.66M | 2.87M | 1.45M | 1.72M | 1.76M | 2M | 2.24M | 2.48M | 2.86M | 3.27M | 3.67M | 3.86M | 5.19M | 5.56M | 6.05M |
Total Assets | 30.16K | 25.87M | 30.16M | 36.13M | 44.72M | 56.42M | 66.91M | 76.2M | 86.65M | 91.68M | 97.69M | 19.27M | 24.96M | 35.26M | 40.76M | 46.91M | 55.19M | 64.32M | 67.05M | 81.32M | 133.98M | 149.17M |
Account Payables | 1.04K | 261K | 1.04M | 1.2M | 1.41M | 3.53M | 2.71M | 3.99M | 4.52M | 2.8M | 1.66M | 716K | 1.16M | 2.21M | 2.39M | 2.52M | 1.43M | 3.61M | 6.51M | 7.62M | 10.08M | 3.49M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 33.38M | n/a |
Other Current Liabilities | 413 | 86K | 413K | 1.71M | 819K | 1.84M | 2.74M | 2.38M | 2.05M | 3.64M | 1.65M | 4.45M | 4.38M | 4.4M | 2.58M | 2.15M | 1.86M | 1.55M | 2.96M | 3.49M | 3.59M | 3.89M |
Total Current Liabilities | 2.4K | 1.24M | 2.4M | 4.04M | 5.84M | 12.29M | 14.82M | 12.66M | 11.75M | 6.93M | 7.54M | 6.45M | 6.37M | 7.52M | 9.35M | 6.84M | 6.84M | 8.59M | 18.41M | 21M | 57.62M | 21.55M |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 33.27M |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.31M | 1.31M | 1.31M | 1.31M | 1.31M | 211K | n/a | n/a | n/a | n/a | 657K | 658K | 663K |
Total Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 25K | 1.38M | 1.41M | 1.31M | 1.31M | 1.31M | 211K | n/a | n/a | n/a | n/a | 1.43M | 1.47M | 34.72M |
Total Liabilities | 2.4K | 1.24M | 2.4M | 4.04M | 5.84M | 12.29M | 14.82M | 12.66M | 11.78M | 8.31M | 8.95M | 7.76M | 7.69M | 8.83M | 9.56M | 6.84M | 6.84M | 8.59M | 18.41M | 22.43M | 59.09M | 56.27M |
Total Debt | n/a | n/a | n/a | n/a | 25K | 63K | 99K | 123K | 145K | 180K | 214K | n/a | n/a | n/a | n/a | n/a | 31K | 117K | 349K | 1.05M | 34.62M | 34.71M |
Book Value | 27.77K | 24.64M | 27.77M | 32.09M | 38.88M | 44.13M | 52.09M | 63.54M | 74.87M | 83.37M | 88.74M | 11.51M | 17.27M | 26.43M | 31.2M | 40.07M | 48.36M | 55.73M | 48.64M | 58.89M | 74.89M | 92.9M |
Book Value Per Share | 0.65 | 28.80 | 32.46 | 37.53 | 45.47 | 51.71 | 61.15 | 74.60 | 87.90 | 97.90 | 142.89 | 175.38 | 264.10 | 405.38 | 522.65 | 622.58 | 751.35 | 905.61 | 817.78 | 1.02K | 1.31K | 1.71K |
Common Stock | 3 | 3K | 3K | 3K | 2K | 2K | 1K | 1K | 1K | 1K | 1K | n/a | n/a | n/a | n/a | 6K | 6K | 6K | 5K | 5K | 5K | 5K |
Retained Earnings | -757.65K | -761.24M | -757.65M | -752.82M | -745.54M | -739.78M | -731.17M | -719.15M | -706.99M | -697.59M | -691.34M | -685.15M | -678.56M | -668.51M | -662.74M | -652.79M | -643.33M | -634.86M | -639.53M | -627.96M | -606.67M | -586.75M |
Comprehensive Income | n/a | n/a | 2K | 4K | -2K | n/a | 20K | 34K | -58K | -70K | 26K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shareholders Equity | 27.77K | 24.64M | 27.77M | 32.09M | 38.88M | 44.13M | 52.09M | 63.54M | 74.87M | 83.37M | 88.74M | 11.51M | 17.27M | 26.43M | 31.2M | 40.07M | 48.36M | 55.73M | 48.64M | 58.89M | 74.89M | 92.9M |
Total Investments | 4.98K | 297K | 4.98M | 13.35M | 17.6M | 22.06M | 41.59M | 53.91M | 48.49M | 66.89M | 62.63M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.03M |
Add to Watchlist
Select watchlists to add or remove VYNE